ライフサイエンスコーパス: IFA

1 IFA e-mail messages were sent for 52 883 (93.3%) of the

2 IFA of sPLA2-IIa, -V, and -X in DE CNJ confirmed the upr

3 (-)(2)(0)/CFA, but not with IRBP(1)(-)(2)(0)/IFA.

4 However, exposure of S2-16:IFA-induced cells to inflammatory cytokine IL-12 convert

5 Adoptive transfer of S2-16:IFA-induced splenocytes producing IL-10 suppressed myoca

6 e transfer of IL-10-producing DCs from S2-16:IFA-treated rats also induced protection to EAM in recip

7 Purified DCs from S2-16:IFA-treated rats promoted S2-16-reactive CD4+ T cells to

8 gs, immunizations using CFA but not CpG 1826/IFA as an adjuvant elicited a delayed-type hypersensitiv

9 ive immunizations using CFA but not CpG 1826/IFA as an adjuvant induced disease.

10 unizations using the autoantigen in CpG 1826/IFA result in very low frequencies of Ag-specific IL-17

11 e when cells originated from PLP in CpG 1826/IFA-primed mice.

12 IL-17-secreting cells compared with CpG 1826/IFA.

13 With a 1:256 IFA titer as the positive cutoff, the agreement, sensiti

14 r the children from 6 to 24 mo (IFA-LNS), 3) IFA (as above) and MNP for the offspring from 6 to 24 mo

15 offspring from 6 to 24 mo (IFA-MNP), and 4) IFA (as above) and no child supplement (IFA-Control).

16 amide (MFA) or 4-hydroperoxyifosfamide (4OOH-IFA), chemically activated forms of CPA and its isomer i

17 d in 9L cells treated with CPA, MFA, or 4OOH-IFA, implicating the mitochondrial apoptotic pathway in

18 Only 3 of 53 IFA-negative samples tested positive on the rMAP2 ELISA.

19 e suggests that the head domain of the MUA-6/IFA-2 is dispensable for its function.

20 Although MUA-6/IFA-2 is expressed embryonically, and plays an essential

21 e filament (cIF) A2 protein and that a MUA-6/IFA-2::GFP fusion protein that rescues the presumptive m

22 ere provided with one daily iron-folic acid (IFA) capsule, one capsule containing multiple micronutri

23 ough 6 mo postpartum or iron and folic acid (IFA) capsules during pregnancy and calcium placebo capsu

24 to 24 mo (LNS-LNS), 2) iron and folic acid (IFA) during pregnancy and the first 3 mo postpartum and

25 micronutrients (MMN) or iron and folic acid (IFA) in Indonesia.

26 ore (LAZ) at 24 mo than iron and folic acid (IFA) provided to women during pregnancy and postpartum p

27 nutrient (MM) compared with iron folic acid (IFA) supplementation from early pregnancy improved birth

28 pplementation compared with iron-folic acid (IFA) supplementation was examined for its impact on grow

29 e micronutrients (MMN) or iron + folic acid (IFA), versus folic acid (FA) alone, on risk of spontaneo

30 tricted to provision of iron and folic acid (IFA).

31 are comprising CSB+ and iron and folic acid (IFA).

32 s; 48 clusters received iron and folic acid (IFA; 60 mg Fe + 400 mug folic acid) and 16 clusters rece

33 ed with either Freund's incomplete adjuvant (IFA) or phosphate buffered saline (PBS) at monthly inter

34 delivered with incomplete Freund's adjuvant (IFA(OVA)).

35 an emulsion of incomplete Freund's adjuvant (IFA) as a co-delivery vehicle, it was discovered that th

36 to neonates in incomplete Freund's adjuvant (IFA) induced such cells in reduced numbers compared to t

37 immunized with incomplete Freund's adjuvant (IFA) remain susceptible.

38 d with IRBP in incomplete Freund's adjuvant (IFA), lacking mycobacteria (whereas the same mice exhibi

39 E2 peptide2 in incomplete Freund's adjuvant (IFA), resulted in higher antibody production and earlier

40 -16 peptide in incomplete Freund's adjuvant (IFA).

41 mulsified with incomplete Freund's adjuvant (IFA).

42 than benchmark incomplete Freund's adjuvant (IFA).

43 ens that were positive by cell culture or AG-IFA were positive by the NASBA assay.

44 infected animals, and 94.3% agreement among IFA-negative samples, resulting in a 97.2% overall agree

45 There was 100% agreement among IFA-positive samples from experimentally infected animal

46 ally infected animals, 97.3% agreement among IFA-positive samples from naturally infected animals, an

47 7 to determine how many reports contained an IFA statement, how many IFA messages were sent, and how

48 mmends that the positive titer cutoff for an IFA be 1:256.

49 One donor (0.25%) had an IFA-confirmed reactivity to anti-T. cruzi antibodies.

50 In an IFA study with B. dermatitidis, serum with an anti-mouse

51 In an IFA, MAb 4F11 detected antigens on the S. pneumoniae sur

52 at any laboratories attempting to replace an IFA type 1 to 6 screen with an alternative ELISA careful

53 Immunofluorescence analysis (IFA) and fluorescence in situ hybridization (FISH) show

54 Immunofluorescence analysis (IFA) and plasma membrane isolation and proximity ligatio

55 s were higher in the LNS-LNS (P = 0.016) and IFA-LNS groups (P = 0.006) at 18 mo and in the IFA-MNP g

56 t were higher in the LNS-LNS (P = 0.035) and IFA-MNP (P = 0.002) groups than in the IFA-Control group

57 Our data indicate that IFB-1 and IFA-3 are likely the major cIF isoforms in embryonic epi

58 Two other cIFs, IFA-2 and IFA-3, are expressed in epidermal cells.

59 ion of enzyme-linked immunosorbent assay and IFA.Results.

60 assayed by Northern blot, Western blot, and IFA experiments.

61 CD8+ T lymphocytes compared to controls and IFA(OVA) treated mice.

62 11 was 7- to 8-fold more active as a CPA and IFA 4-hydroxylase than 2B1, exhibited a highly desirable

63 Improved catalytic efficiency of CPA and IFA 4-hydroxylation was obtained upon substitution of 2B

64 CPA and IFA metabolism catalyzed by P450s 2B1, 2B4, 2B5, and sev

65 The concordance between EIA and IFA findings was 96.7%.

66 We compared ELISA and IFA testing on sera from 305 suspected cases of Lassa fe

67 n induced with keyhole limpet hemocyanin and IFA did not affect corneal allograft rejection.

68 t biomarkers in relation to antenatal MM and IFA supplementation and maternal gestational micronutrie

69 elative risks of SPB for those using MMN and IFA were 0.99 (95% confidence interval: 0.85, 1.16) and

70 rum samples from Bartonella PCR-negative and IFA-negative dogs, and group IV consisted of serum sampl

71 mmunofluorescent antibody (IFA)-positive and IFA-negative dogs.

72 poridium concentrations measured by qPCR and IFA were significantly correlated ( p < 0.001).

73 Western blot analysis with an antibody (IFA) that selectively labels all known intermediate fila

74 developed an indirect fluorescence antibody (IFA) test for the detection of antibodies to B. bacillif

75 s detected by indirect fluorescent antibody (IFA) assay.

76 a whole-cell indirect fluorescent antibody (IFA) test and two multiantigen tests, but not with singl

77 Indirect fluorescent-antibody (IFA) testing on cerebrospinal fluid and serum specimens

78 icroscopy (EM), immunofluorescence antibody (IFA) testing of sera, case tracing, containment, and epi

79 By the sandwich immunofluorescent antibody (IFA) method with anti-mouse MBL (MBL-A or -C), we showed

80 es from E. canis immunofluorescent antibody (IFA)-positive and IFA-negative dogs.

81 ually as well as immunofluorescent-antibody (IFA) assay when J774.16 cells were infected with 10-fold

82 ons about anaphylaxis to imported fire ants (IFAs).

83 Using a two-step diagnostic approach (IFA is performed if the ELISA is positive), we identifie

84 n indirect immunofluorescent-antibody assay (IFA) by using a local human isolate as the source of ant

85 y indirect immunofluorescent-antibody assay (IFA).

86 rnal N. caninum indirect fluorescence assay (IFA) at a 1:200 serum dilution, a relative standard set

87 n blotting, and an immunofluorescence assay (IFA) against a panel of sera from patients with Oroya fe

88 tected by indirect immunofluorescence assay (IFA) and immunohistochemistry with a specific rabbit ant

89 confirmed with an immunofluorescence assay (IFA) available through the Centers for Disease Control (

90 to an IgG-specific immunofluorescence assay (IFA) for L. pneumophila serogroups 1 to 6.

91 st to the indirect immunofluorescence assay (IFA) for scrub typhus.

92 ection by indirect immunofluorescence assay (IFA) is the reference standard due to its presumed high

93 Immunofluorescence assay (IFA) of the sPLA2-IIa, -V, and -X isoforms were used to

94 ng either indirect immunofluorescence assay (IFA) or a combination of enzyme-linked immunosorbent ass

95 igital microscopic immunofluorescence assay (IFA) that incorporates beta-catenin detection and cellul

96 shown by indirect immunofluorescence assay (IFA) to bind surface antigens of P. carinii derived from

97 al-time PCR and an immunofluorescence assay (IFA) using anti-TTSuV antibodies.

98 ade by an indirect immunofluorescence assay (IFA) using cultured ehrlichia-infected whole cells as an

99 an ELISA and by an immunofluorescence assay (IFA) using PK-15 cells transfected with one of the three

100 nt use of an HHV-8 immunofluorescence assay (IFA) was tested in persons unlikely to be infected with

101 roach involving an immunofluorescence assay (IFA), a differential recombinant IFA, and a plaque-reduc

102 n of culture, MAT, immunofluorescence assay (IFA), lateral flow (LF) and/or PCR targeting the 16S rRN

103 cimens by indirect immunofluorescence assay (IFA).

104 virus by indirect immunofluorescence assay (IFA).

105 ce, as observed by immunofluorescence assay (IFA).

106 dermatitidis in an immunofluorescence assay (IFA).

107 ridium by qPCR and immunofluorescence assay (IFA).

108 Double-label immunofluorescence assays (IFA) performed with Ad-ZTA-infected HF cells revealed th

109 Immunofluorescence assays (IFA) specific for double-stranded RNA (dsRNA) demonstrat

110 d with those from immunofluorescence assays (IFA).

111 eutralization and immunofluorescence assays (IFA).

112 tivity of immunofluorescent-antibody assays (IFAs), a reliable serodiagnostic test for canine bartone

113 , CA) and matched immunofluorescence assays (IFAs; MBL Bion, Des Plaines, IL) in 220 HCWs categorized

114 ogical (4 indirect immunofluorescent assays [IFA] and 2 enzyme-linked immunosorbent assays-both HHV8

115 anisms, therefore, contribute to autoantigen:IFA-induced protection from autoimmune disease.

116 rmance was obtained by 2 lytic antigen-based IFAs that showed almost perfect agreement to the referen

117 Because IFA testing for rabies on human specimens may result in

118 st measles, mumps, and VZV, Bio-Rad MFI/Bion IFA positivity rates were 77.4%/93%, 84.8%/90.7%, and 54

119 Comparatively, the Bion IFA was positive in 92.9, 91.1, and 93.5% of HCWs presum

120 ot result in fluorescence, yet serum blocked IFA staining of B. dermatitidis by anti-1,3-beta-glucan

121 Both IFA and CFA, however, provided partial protection from a

122 esumed high sensitivity and specificity, but IFA is impractical, variably reproducible, and cumbersom

123 us-based VP1 immunofluorescence assays (BVP1 IFAs) (Biotrin International).

124 By IFA cells expressing neutralization sensitive envelope b

125 By IFA testing, 36 of 38 cattle had antibodies (> or =1:64)

126 By IFA, the patient's serum reacted strongly to two out of

127 wells, wells positive for Cryptosporidium by IFA would likely be required to add treatment.

128 tive standard set of 330 cow sera defined by IFA alone, and a set of 4,323 cow sera of unknown N. can

129 n BALF to B. dermatitidis as demonstrated by IFA.

130 ction and was detected on B. dermatitidis by IFA.

131 lei, especially in nucleoli, was detected by IFA.

132 s that recognize parasitized erythrocytes by IFA and native PyP140/RON4 by immunoblotting but failed

133 s papio IgG antibody titers were measured by IFA.

134 CR, and of these samples 67 were positive by IFA.

135 hird of the healthy blood donors reactive by IFA were confirmed to be positive by immunoblotting.

136 the influenza A virus subtyping reagents by IFA simultaneously.

137 anti-1,3-beta-glucan antibody, we showed by IFA assay that B. dermatitidis contained 1,3-beta-glucan

138 -C, which bound B. dermatitidis, as shown by IFA assay.

139 ated with canine ehrlichiosis were tested by IFA assay and by recombinant Western immunoblot.

140 isted of serum samples from 8 Brucella canis IFA-positive and 10 Rickettsia rickettsii IFA-positive d

141 Patients were tested with AdenoPlus, CC-IFA, and PCR to detect the presence of adenovirus.

142 When compared with both CC-IFA and PCR, AdenoPlus showed a sensitivity of 93% (27/2

143 results were found to be positive by both CC-IFA and PCR.

144 sults were found to be positive by either CC-IFA or PCR and 29 patients' results were found to be pos

145 When compared with PCR, CC-IFA showed a sensitivity of 85% (29/34) and specificity

146 When compared only with CC-IFA, AdenoPlus showed a sensitivity of 90% (28/31) and s

147 assay was more sensitive than the whole-cell IFA and ELISA using purified, recombinant histidine-tagg

148 All 16 E. chaffeensis IFA-positive sera reacted with rP30.

149 Two other cIFs, IFA-2 and IFA-3, are expressed in epidermal cells.

150 art is devoid of MHC class II expression, CM-IFA administration delays rejection of fully allogeneic

151 CM/IFA treatment prevents acute rejection of MHC class I-mi

152 t administration of CM together with IFA (CM/IFA) can prevent acute rejection of an allogeneic heart

153 In contrast, IFA-2 is not required for embryonic morphogenesis.

154 respectively, could be used to discriminate IFA dually reacting sera.

155 randomly assigned 262 midwives to distribute IFA (n=15 ,86) or MMN (n=15,804) supplements to 31 290 p

156 ized with MOG 35-55/CFA or MOG 35-55/CpG DNA/IFA.

157 Thirteen dually IFA-reactive sera, three sera that were IFA positive onl

158 vimentin (V) at subcellular resolution ("EMT-IFA").

159 ogeneity in human carcinomas exists; the EMT-IFA allows for clinical monitoring of tumor adaptation t

160 incidence in women who started consuming FA, IFA, and MMN before the 12th week of gestation (4.6%, 4.

161 he incidences of SPB for women consuming FA, IFA, and MMN were 5.7%, 5.6% and 5.1%, respectively.

162 were randomly assigned to receive daily FA, IFA, or MMN from the period before 20 weeks' gestation t

163 Starting use of FA, IFA, or MMN supplements before the 12th week of gestatio

164 NS, P = 0.022 for IFA-LNS, and P = 0.009 for IFA-MNP compared with IFA-Control).

165 24 mo (P = 0.008 for LNS-LNS, P = 0.022 for IFA-LNS, and P = 0.009 for IFA-MNP compared with IFA-Con

166 climate change and ecologic competition from IFA.

167 higher in procedural memory than those given IFA, equivalent to the increase in scores with half a ye

168 mortality compared with those of women given IFA (35.5 deaths per 1000 livebirths vs 43 per 1000; rel

169 useful in discriminating dually HME and HGE IFA-reactive sera.

170 Cyclophosphamide (CPA) and ifosfamide (IFA) are oxazaphosphorine anticancer prodrugs metabolize

171 ushi, three different PCR assays, and an IgM IFA.

172 Dx, Inc., Baltimore, Md.), 52%; Biognost IgM IFA test (Bios GmbH Labordiagnostik, Grafelfing, Germany

173 as an alternative reference test to the IgM IFA for the serological diagnosis of scrub typhus.

174 accuracy and is less subjective than the IgM IFA.

175 also tested by indirect immunofluorescence (IFA).

176 EAE conferred by injection of PLPp139-151 in IFA and induced high frequencies of peptide-specific Th1

177 MBP epitope for this strain, administered in IFA.

178 MP4 administration in IFA induced type 2 T cell immunity, IgG1 Abs, and experi

179 MB Igmu(-/-) NOD mice with a beta cell Ag in IFA induced Th2 responses, which spread to other beta ce

180 d that the injection of each of these Ags in IFA was immunogenic and CD4 memory cells producing IL-2,

181 l T reg cell activity to retinal arrestin in IFA).

182 ation with the AIG target Ag, H/K ATPase, in IFA failed to induce disease in normal animals but induc

183 DBA/1 mice were immunized with CII in IFA and injected intraperitoneally with rIFN gamma (8,00

184 determined whether immunization with CII in IFA had the capacity to prevent and/or ameliorate collag

185 FA) and treated with a single dose of CII in IFA on the day of immunization or on the day of disease

186 A single intraperitoneal injection of CII in IFA prevented arthritis when given at the time of immuni

187 or rIFN gamma to mice immunized with CII in IFA restored the Th1 response and resulted in the develo

188 The administration of CII in IFA resulted in a profound down-regulation of IFN gamma

189 booster on day 21, which consisted of CII in IFA.

190 njection of bovine type II collagen (CII) in IFA with added Mycobacterium tuberculosis on days 0 and

191 s.c. administration of repeated low doses in IFA.

192 peptide and a pool of epitopes emulsified in IFA elicited similar levels of CD8(+) responses using fr

193 antigen in multiple sclerosis) emulsified in IFA fail to mount lymphoproliferative or cytokine respon

194 ed with peptide or protein Ags emulsified in IFA or related water-in-oil adjuvants develop a highly p

195 ith NY-ESO-1(157-170) peptide (emulsified in IFA) in patients with NY-ESO-1-expressing epithelial ova

196 We show that loss of function in IFA-3 results in defects in morphogenesis indistinguisha

197 observed when MP4 was repeatedly injected in IFA or as soluble Ag s.c.

198 The gland dysfunction observed in IFA-treated mice at earlier time points did not correlat

199 oxp3 expression upon stimulation with OVA in IFA in vivo.

200 A high dose of alpha 146--162 peptide in IFA failed to suppress T cell proliferation and/or clini

201 A high dose of alpha 146--162 peptide in IFA in AChR-immunized mice induced apoptosis of BV6 cell

202 ination of mice with gp100(25-33) peptide in IFA.

203 blished EAE were treated with E2 peptide2 in IFA to develop antibody.

204 inia virus, or epitope delivery as a pool in IFA maintained the overall response pattern; however, ch

205 , but not when the peptide was reinjected in IFA.

206 , Saudi Arabia, 8 reactive sera were seen in IFA but were resolved to be specific for established HCo

207 ptide IRBP(1)(-)(2)(0) in either incomplete (IFA) or complete (CFA) Freund's adjuvant.

208 men received IFA and children received LNSs (IFA-LNS group), 3) women received IFA and children recei

209 Serological assays, specifically lytic IFAs, were the best methodological approach to identify

210 reports contained an IFA statement, how many IFA messages were sent, and how many such messages were

211 nse as revealed by epitope affinity mapping, IFA and inhibition of the complement lysis assays.

212 n terms of exposure, sex, detection methods, IFA titre, Legionella species measured, and present sero

213 comparison: LNS compared with non-LNS (MMN + IFA).

214 omen received IFA and children received MNP (IFA-MNP group), and 4) women received IFA and children r

215 m and LNSs for the children from 6 to 24 mo (IFA-LNS), 3) IFA (as above) and MNP for the offspring fr

216 ) and MNP for the offspring from 6 to 24 mo (IFA-MNP), and 4) IFA (as above) and no child supplement

217 ionship between alpha-Gal cases and cases of IFA anaphylaxis that were closely related to the territo

218 y and quickly, in contrast to the reading of IFA slides, which was both subjective and labor-intensiv

219 these sera reacted with rP44, regardless of IFA reactivity with the HGE agent.

220 hat were closely related to the territory of IFA.

221 The three HGE-agent-only IFA-positive sera reacted only with rP44, not with rP30.

222 on following immunization with Ags in CFA or IFA or alum.

223 mmunization with GalXM in either complete or IFA was associated with spleen enlargement in BALB/c mic

224 ting allergic reactions to mammalian meat or IFA.

225 more, we found that i.p. injection with p524/IFA was very effective in providing protection from cycl

226 Peptide/IFA vaccination primed tumor-specific CD8(+) T cells, wh

227 ide in incomplete Freund's adjuvant (peptide/IFA), which is commonly used in clinical cancer vaccine

228 Patients received peptides/IFA with or without interleukin (IL)-12 30 ng/kg to eval

229 However, at this time point IFA-treated mice showed significantly higher frequencies

230 ps at early time points, by late time points IFA-treated mice had higher levels.

231 Because false-positive IFA results could significantly affect patient treatment

232 Regardless of where the positive IFA cutoff titer is placed, however, the sensitivity of

233 results can occur in interpreting the rabies IFA test.

234 ived LNSs (LNS-LNS group), 2) women received IFA and children received LNSs (IFA-LNS group), 3) women

235 ived LNSs (IFA-LNS group), 3) women received IFA and children received MNP (IFA-MNP group), and 4) wo

236 d MNP (IFA-MNP group), and 4) women received IFA and children received no supplements (IFA-Control gr

237 ence assay (IFA), a differential recombinant IFA, and a plaque-reduction serum neutralization assay.

238 is IFA-positive and 10 Rickettsia rickettsii IFA-positive dogs.

239 immune to measles, mumps, and VZV (a rubella IFA was unavailable).

240 WB were higher than those of B. henselae SA2 IFA testing.

241 cificity was 96.8% for the relative standard IFA-defined sera.

242 In this study, IFA testing was performed on 135 cerebrospinal fluid and

243 quired by the more cumbersome and subjective IFA testing to <20%.

244 This subtyping IFA provides clinical laboratories with a cost-effective

245 th the usual iron and folic acid supplement (IFA) on survival, growth, and morbidity during infancy.

246 d 4) IFA (as above) and no child supplement (IFA-Control).

247 ed IFA and children received no supplements (IFA-Control group).

248 otoxic T lymphocytes with immune memory than IFA-emulsifying vaccines.

249 ignificantly (P < 0.05) more repeatable than IFA when 2-fold dilutions were used.

250 The IFA system is a potentially useful method of communicati

251 The IFA was performed on samples within a range of EIA optic

252 ly of putative transcription factors and the IFA family of putative transmembrane proteins in C. albi

253 elected radiology reports that contained the IFA statement to identify the imaging modalities and fin

254 total of 56 691 (3.7%) reports contained the IFA statement.

255 95% CI: 0.39, 0.96; P = 0.032) than did the IFA group.

256 -age z score (+0.40; P = 0.022) than did the IFA group; similar differences were found when comparing

257 ely) were significantly greater than for the IFA (79.1 +/- 2.9 cm and -0.87 +/- 0.99) and MMN (79.1 +

258 (58%) to walk alone at age 12 mo than in the IFA (49%) and MMN (49%) groups.

259 S group was 8.9%, compared with 13.7% in the IFA group and 12.9% in the MMN group (P = 0.12).

260 rmediate in the MMN group, and lowest in the IFA group, but except for midupper arm circumference (P

261 to 12 mo of age in the MM group than in the IFA group, but not from 12 to 24 mo of age.

262 at 6 mo of age compared with children in the IFA group.

263 -1.66 +/- 1.03; P = 0.005) than those in the IFA group; in adjusted models, the differences in length

264 ): <-2] was 31.9% in the MM and 35.7% in the IFA groups (P < 0.001); however, LAZ increased during th

265 2.2, and 49.9 +/- 2.1 cm (P = 0.104) in the IFA, MMN, and LNS groups, respectively.

266 ) and IFA-MNP (P = 0.002) groups than in the IFA-Control group at 24 mo.

267 er in the LNS-LNS group at 18 mo than in the IFA-MNP group (OR: 0.70; 95% CI: 0.53, 0.92), but the di

268 A-LNS groups (P = 0.006) at 18 mo and in the IFA-MNP group (P = 0.048) at 24 mo.

269 nventional cutoff titer of 80 is used in the IFA.

270 that triggered the radiologists' use of the IFA system.

271 r cells was shown to be one mechanism of the IFA-induced tolerance.

272 used to examine convalescent-phase sera, the IFA is positive in 93% of bartonellosis cases.

273 CI: 0.12, 1.08; P = 0.040) earlier than the IFA group and standing with assistance earlier than the

274 In addition, while the IFA-primed T cells acted as suppressor cells, in that th

275 rcumference (+0.15 z score compared with the IFA-Control group); these outcomes did not differ betwee

276 364), and 24 (n = 3379) mo.Compared with the IFA-Control group, motor development scores were higher

277 ficantly higher LAZ (+0.13 compared with the IFA-MNP group) and head circumference (+0.15 z score com

278 of the recombinant proteins compared to the IFAs was 96% for rP28, 88% for P43 and 63% for P140.

279 of low SLP doses in the slow-release vehicle IFA prevented the anaphylaxis after repeated vaccination

280 showed a positive coefficient of MMN versus IFA (p=0.0431) with effect sizes from 0.00-0.18 SD.

281 Among the 22 samples that were IFA positive for E. canis, 100% reacted with rP43, 96% r

282 ally IFA-reactive sera, three sera that were IFA positive only with E. chaffeensis, and three sera th

283 ith E. chaffeensis, and three sera that were IFA positive only with the HGE agent were examined by We

284 While IFA-treated mice had significantly decreased salivary se

285 With IFA, approximately 50% of metabolism proceeded via N-dec

286 assay, demonstrating rates of agreement with IFA of >/=98%.

287 uivalent or superior rates of agreement with IFA-positive specimens across all titers examined.

288 e samples, and there was 100% agreement with IFA.

289 (ELISA) for use alone or in combination with IFA.

290 ternal MMN supplementation, as compared with IFA, can reduce early infant mortality, especially in un

291 rnal supplementation with MMN, compared with IFA, on fetal loss and infant death in the setting of ro

292 LNS, and P = 0.009 for IFA-MNP compared with IFA-Control).

293 r the RUSF, CSB+ with UNIMMAP, and CSB+ with IFA groups, respectively; P = 0.03).

294 groups (17%, 18%, and 24% for the CSB+ with IFA, RUSF, and CSB+ with UNIMMAP groups, respectively; P

295 Mtb 8.4 recombinant protein formulated with IFA elicited strong CD4(+) T cell and CD8(+) CTL respons

296 show that administration of CM together with IFA (CM/IFA) can prevent acute rejection of an allogenei

297 from seven melanoma patients vaccinated with IFA, CpG, and the native/EAA or analog/ELA Melan-A(MART-

298 25/pfmget qRT-PCR; this correlated well with IFA results (Pearsons r2 = 0.91; P < .001).

299 This analysis included 1057 women (IFA = 349, MMN = 354, LNS = 354).

300 Among primiparous women (IFA = 131; MMN = 110; LNS = 128), the LNS group had grea